Loading clinical trials...
Loading clinical trials...
Diabetes contributes significantly to the burden of disease in Norway and cardiovascular disease is the main cause of mortality. Both lean and fatty fish are shown to have beneficial health effects. ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Oslo
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT07440147 · Obesity & Overweight, Circadian Rhythm Disorders, and more
NCT02969798 · Diabetes Mellitus, Type 2, Impaired Glucose Tolerance (IGT), and more
NCT06964620 · Diabetes Mellitus, Type 2, Impaired Glucose Tolerance
NCT05873322 · Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Induced Diabetes Mellitus, and more
University of Oslo
Oslo, Post Box 1046, Blindern
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions